Today I want to talk about something beginning observers tend to overlook. It a process of the human eye called dark ...

The mean of analysts' price targets for Rigel (RIGL) points to an 82.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts ...

First quarter 2025 total revenue of approximately $53.3 million, which includes net product sales of $43.6 million and contract revenues from collaborations of $9.8 ...

Rigel Pharmaceuticals, Inc.'s 68% YoY revenue growth signals durable stock potential. Click for my RIGL earnings update and a ...

Malcolm Roberts, 32, has pending charges for fleeing/eluding officers in a motor vehicle, speeding, driving with no insurance ...

Bravo is heading to the smallest state for some more big drama as it orders its latest spinoff of The Real Housewives. The ...

NewAmsterdam's obicetrapib reduced Lp(a) by 45% in Phase 3; C4 Therapeutics advances cemsidomide while dropping CFT1946; Vivo ...

Rigel Pharmaceuticals reports strong Q1 2025 growth, with revenue up 68% YoY. Learn about their $200M+ guidance, robust pipeline, and market strategy.

Rigel Pharmaceuticals, Inc.’s RIGL share price has surged by 27.08%, which has investors questioning if this is right time to ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported first-quarter profit of $11.4 million. The South San Francisco, ...

Local elected officials have adapted to today’s tech-dominated media landscape by crafting online personas and digitally ...

Analysts are estimating that Rigel Pharmaceuticals will report an earnings per share (EPS) of $0.09. Investors in Rigel ...